Title
Category
Credits
Event date
Cost
Highlights of SNO & EANO 2022 Annual Meetings
  • Pathology
  • 1.00 Attendance
$0.00
Highlights of SNO-EANO 2022: Tuesday February 14, 2023, at 12:30pm-1:30pm ESTComplimentary Registration!Registration is free and limited to the first 1,000 participants. All SNO webinars are recorded, so if you miss one, you will be able to view it on-demand through the Neuro-Oncology Academy. 
Primary Central Nervous System Lymphoma: An Update on Diagnosis & Management
  • Neurological Complications
  • Clinical Neuro-Oncology for the Basic Scientist
$0.00
March 28, 2023: Craniopharyngioma: More Than Meets the Eye
  • Pediatrics NeuroOnc
  • 1.50 Attendance
$0.00
 Craniopharyngioma: More Than Meets the EyeThe Pediatric Special Interest Track of the Society for Neuro-Oncology is pleased to present the Pediatric Tumor Board webinar series. Registration is free and limited to the first 1,000 participants.
Role of DNA Methylation for diagnosis and clinical management in neuro-oncology
  • Pathology
$0.00
This course will discuss principles of DNA methylation and suitability for routine brain tumor diagnostics. An overview of the method, and impact on accurate diagnostics for newly diagnosed and recurrent tumors will be presented. Furthermore, the role of DNA methylation in avoiding diagnostic errors and accurately diagnose brain tumors, which were unclassifiable using routine diagnostic tools will be discussed.
Pediatric Tumor Board & AYA IDH-Mutant Gliomas: Bridging the Gap
  • Pediatrics NeuroOnc
  • 1.50 Attendance
$0.00
 IDH-Mutant Glioma in Adolescents and Young Adults (AYA)The Pediatric Special Interest Track of the Society for Neuro-Oncology is pleased to present the Pediatric Tumor Board webinar series. Registration is free and limited to the first 1,000 participants.
SNO Grand Rounds: IDH Mutant Glioma: Pivotal Results and Discussion of the INDIGO Trial Recording
  • Clinical Trials
$0.00
The Neuro-Oncology Academy is pleased to announce the first CME webinar in the SNO Grand Rounds Series, IDH Mutant Glioma: Pivotal Results and Discussion of the INDIGO Trial, an activity provided by the Society for Neuro-Oncology. This recorded course is not for credit. 

Pages